Research Progress of Anti-lung Cancer Drugs

Abstract

Lung cancer is the highest incidence of a disease and mortality in China. The incidence of a disease and mortality of lung cancer in China is among the highest in the world, and the probability of survivability is lower than other countries. However, there are still some practical issues in clinical practice, such as large toxic side effects of chemotherapeutic drugs, drug resistance, and fewer people who benefit from immunotherapy. Therefore, this paper aims to find a more safe, effective and reliable combination of drugs. In this paper, through reading, searching and screening a large number of basic and clinical studies, it is concluded that traditional Chinese medicine can not only play an anti-tumor effect through a variety of ways, but also prolong the survival period of patients with cancer and improve the quality of life of patients. In this paper, Astragalus membranaceus and Glycyrrhiza uralensis Fisch are selected as the legume of anti-lung cancer drugs. The effective components, pharmacological activity properties, anti-lung cancer mechanism and clinical application of treatment of lung cancer of Astragalus membranaceus and Glycyrrhiza uralensis Fisch are systematically combed in order to provide theoretical basis for the treatment and prevention of lung cancer.